Lack of an Association Between Insulin-like Growth Factor-I and Body Composition, Muscle Strength, Physical Performance or Self-Reported Mobility Among Older Persons with Functional Limitations

1998 ◽  
Vol 46 (7) ◽  
pp. 822-828 ◽  
Author(s):  
Douglas P. Kiel ◽  
Jacqueline Puhl ◽  
Clifford J. Rosen ◽  
Katherine Berg ◽  
John B. Murphy ◽  
...  
1998 ◽  
Vol 83 (5) ◽  
pp. 1477-1484 ◽  
Author(s):  
J. L. Thompson ◽  
G. E. Butterfield ◽  
U. K. Gylfadottir ◽  
J. Yesavage ◽  
R. Marcus ◽  
...  

To determine the effects of GH and insulin-like growth factor I (IGF-I) administration, diet, and exercise on weight loss, body composition, basal metabolic rate (BMR), muscle strength, and psychological status, 33 moderately obese postmenopausal women (67.1 ± 5.2 yr) participated in a 12-week randomized, double blind study. Participants were placed on a diet that provided 500 Cal/day less than that needed for weight maintenance, and they walked 3 days and strength trained 2 days each week. Subjects also self-injected GH (0.025 mg/kg BW·day), IGF-I (0.015 mg/kg BW·day), a combination of these doses of GH and IGF-I, or placebo (P). Twenty-eight women completed the study, as five subjects dropped out due to intolerable side-effects (e.g. edema). Weight loss occurred in all groups, with the largest decrease occurring in the GH plus IGF-I group (5.6 ± 1.4 kg). Fat mass significantly decreased in all groups, with the largest losses observed in GH and GH plus IGF-I groups (6.3 ± 1.8 and 8.4 ± 2.8 kg, respectively). Despite weight loss, BMR was maintained in all groups. Muscle strength increased with training for all groups, and depression and anxiety scores decreased in groups receiving IGF-I. These data show that obese postmenopausal women can lose weight and fat without compromising fat free mass, BMR, or gains in muscle strength, and that GH and IGF-I given together may enhance fat loss over either given alone.


2003 ◽  
Vol 24 (4) ◽  
pp. 573-581 ◽  
Author(s):  
Miranda G Dik ◽  
Saskia M.F Pluijm ◽  
Cees Jonker ◽  
Dorly J.H Deeg ◽  
Marie Z Lomecky ◽  
...  

1989 ◽  
Vol 13 (4) ◽  
pp. 392-396 ◽  
Author(s):  
Francesco Minuto ◽  
Antonina Barreca ◽  
Gian Franco Adami ◽  
Patricia Fortini ◽  
Patrizia Del Monte ◽  
...  

2005 ◽  
Vol 90 (1) ◽  
pp. 256-263 ◽  
Author(s):  
Robin P. Peeters ◽  
Annewieke W. van den Beld ◽  
Hans van Toor ◽  
Andre G. Uitterlinden ◽  
Joop A. M. J. L. Janssen ◽  
...  

2000 ◽  
Vol 85 (4) ◽  
pp. 1686-1694 ◽  
Author(s):  
Nelly Mauras ◽  
Kimberly O. O’Brien ◽  
Susan Welch ◽  
Annie Rini ◽  
Kevin Helgeson ◽  
...  

We examined the effects of recombinant human (rh) insulin-like growth factor I (IGF-I) vs. rhGH in a variety of metabolic paths in a group of eight severely GH-deficient young adults using an array of contemporary tools. Protein, glucose, and calcium metabolism were studied using stable labeled tracer infusions of l-[1-13C]leucine,[ 6,6-2H2]glucose, and 42Ca and 44Ca; substrate oxidation rates were assessed using indirect calorimetry; muscle strength was determined by isokinetic and isometric dynamometry of the anterior quadriceps, as well as growth factors, hormones, glucose, and lipid concentrations in plasma before and after 8 weeks of rhIGF-I (60 μg/kg, sc, twice daily), followed by 4 weeks of washout, then 8 weeks of rhGH (12.5 μg/kg·day, sc); the treatment order was randomized. In the doses administered, rhIGF-I and rhGH both increased fat-free mass and decreased the percent fat mass, with a more robust decrease in the percent fat mass after rhGH; both were associated with an increase in whole body protein synthesis rates and a decrease in protein oxidation. Neither hormone affected isokinetic or isometric measures of skeletal muscle strength. However, rhGH was more potent than rhIGF-I at increasing lipid oxidation rates and improving plasma lipid profiles. Both hormones increased hepatic glucose output, but rhGH treatment was also associated with decreased carbohydrate oxidation and increased glucose and insulin concentrations, indicating subtle insulin resistance. Neither hormone significantly affected bone calcium fluxes, supporting the concept that these hormones, by themselves, are not pivotal in bone calcium metabolism. In conclusion, rhIGF-I and rhGH share common effects on protein, muscle, and calcium metabolism, yet have divergent effects on lipid and carbohydrate metabolism in the GH-deficient state. These differences may allow for better selection of treatment modalities depending on the choice of desired effects in hypopituitarism.


Sign in / Sign up

Export Citation Format

Share Document